NCT05744557

Vapocoolant Analgesia for Breast Lymphoscintigraphy

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: M.D. Anderson Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To learn if applying vapocoolant anesthetic spray ("Nüm") on the surface of the intended injection site will reduce the pain/anxiety associated with breast injections.

Detailed description

Primary Objectives: 1. Establish feasibility of topical vapocoolant in the setting of breast lymphoscintigraphy. 2. Demonstrate safety of topical vapocoolant in the setting of breast lymphoscintigraphy. Secondary Objectives: 1. To assess patient pain intensity associated with the performance of breast lymphoscintigraphy. 2. To evaluate the attitude from patients about supporting the continued offering of topical vapocoolant in the breast lymphoscintigraphy clinic.

Conditions

• Breast Cancer

Interventions

Type	Name	Description
OTHER	num Vapocoolant	Spray will be administered for 4 to 6 seconds from a distance of 3 to 6 inches to desired sites of skin

Timeline

• Start date: 2023-03-01
• Primary completion: 2025-05-13
• Completion: 2025-05-13
• First posted: 2023-02-27
• Last updated: 2025-05-20

Locations

1 site across 1 country: United States